The Management of Atopic Dermatitis: Entering a New Paradigm
Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Impact Education, LLC     Postgraduate Institute for Medicine
This activity is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Wednesday, April 25, 2018
6:00 AM - 8:00 AM
Boston Convention and Exhibition Center
Room 109AB
Boston, MA


Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required.
Held in conjunction with

AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018.
Click here to download the slides from this symposium.

Don't miss the live webcast, "The Management of Atopic Dermatitis: Entering a New Paradigm Live Webcast".
Click here to register and for full accreditation information.
  Hot Topics
  • Review of recently approved and emerging therapies
  • Quality standards, health care policy, and benefit designs
  • Care management strategies to boost adherence to treatment plans
  • Current evidence-based diagnosis and treatment data to optimize clinical outcomes
  Expert Faculty Presenters
Jeffrey D. Dunn, PharmD, MBA
Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC
Paul Yamauchi, MD, PhD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Adjunct Associate Professor
John Wayne Cancer Institute
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2018 Managed Care and Specialty Pharmacy Annual Meeting.

  Statement of Need/Program Overview

Atopic dermatitis (AD), or eczema, is a complex, chronic, relapsing inflammatory skin disease marked by pruritus and skin irritation. Recent studies have documented the adverse effects of AD on mental health and quality of life and new evidence suggests a relationship between AD and other chronic, nonallergic conditions including obesity, cardiovascular disease, autoimmunity, and malignancies. This symposium is focused on AD diagnosis and treatment, impact of emerging therapies, adherence to therapy, and management of the pharmacy benefit. It is specifically designed to meet the needs of health care decision makers (HCDMs) from health plans, insurers, health systems, and other payers responsible for the benefit management, therapeutic category review, and AD clinical pathway development.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Review recent insights into the pathophysiology of Atopic Dermatitis (AD)
  • Discuss the safety, efficacy and attributes of emerging therapies for the treatment of AD
  • Evaluate strategies to align diagnosis and treatment strategies with current evidence-based guidelines
  • Apply practical approaches to improve adherence to AD treatment
  • Assess benefit design strategies to improve overall patient outcomes for AD
  Agenda

Date and Time
Wednesday, April 25, 2018
6:00 AM - 8:00 AM
Boston Convention and Exhibition Center
Room 109AB
Boston, MA

6:00 AM Pre-Activity Learning Assessment and Opening Comments/Overview
6:05 AM Clinical Update: The Impact of Novel Therapies
Paul Yamauchi, MD, PhD
6:40 AM Care Management Strategies to Improve Clinical and Economic Outcomes
Edmund Pezalla, MD, MPH
7:10 PM Benefit Design and Specialty Pharmacy Services for Optimal Management
Jeffrey D. Dunn, PharmD, MBA
7:40 AM Audience Q&A Session
7:55 AM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
8:00 AM Adjournment
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-047-L01-P

Type of Activity: Application

For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required.

Pre-registration will close at 12:00 pm on April 24, 2018.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.